“Buprenorphine + Naloxone Plus Naltrexone For The Treatment Of Cocaine Dependence: The Cocaine Use Reduction With Buprenorphine (Curb) Study.”. Addiction 111 (8). Addiction: 1416-27. doi:10.1111/add.13375.
. 2016. “Nida Clinical Trials Network Ctn-0051, Extended-Release Naltrexone Vs. Buprenorphine For Opioid Treatment (X:bot): Study Design And Rationale.”. Contemp Clin Trials 50. Contemp Clin Trials: 253-64. doi:10.1016/j.cct.2016.08.004.
. 2016. “Achieving Cannabis Cessation -- Evaluating N-Acetylcysteine Treatment (Accent): Design And Implementation Of A Multi-Site, Randomized Controlled Study In The National Institute On Drug Abuse Clinical Trials Network.”. Contemp Clin Trials 39 (2). Contemp Clin Trials: 211-23. doi:10.1016/j.cct.2014.08.011.
. 2014. “Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial To Evaluate The Efficacy Of Buspirone As A Relapse-Prevention Treatment For Cocaine Dependence.”. J Clin Psychiatry 75 (7). J Clin Psychiatry: 757-64. doi:10.4088/JCP.13m08862.
. 2014. “Primary Outcome Indices In Illicit Drug Dependence Treatment Research: Systematic Approach To Selection And Measurement Of Drug Use End-Points In Clinical Trials.”. Addiction 107 (4). Addiction: 694-708. doi:10.1111/j.1360-0443.2011.03473.x.
. 2012.